Yvette L Kasamon
6PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas.Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu
|Feb 07, 2024
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma.Mona Elmacken, Helkha Peredo-Pinto, Cong Wang
|Aug 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma.Deepti Telaraja, Yvette L Kasamon, Justin S Collazo
|Jul 05, 2023
FDA Approval Summary: Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma.Poornima Sharma, Yvette L Kasamon, Xue Lin
|Mar 09, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon
Pageof 1
Frequent Collaborators
5 joint publications
Marc R Theoret
4 joint publications
Nicole J Gormley
2 joint publications
Tejashri Purohit-Sheth
2 joint publications
Maryam Sarraf Yazdy
2 joint publications
Rachel Ershler
2 joint publications
Bindu Kanapuru
2 joint publications
Nicholas C Richardson
2 joint publications
Zhenzhen Xu
2 joint publications
Theresa Carioti
2 joint publications
Richard Pazdur